Allspring Global Investments Holdings, LLC Cassava Sciences Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$16.64 - $25.32 $77,093 - $117,307	4,633 New	4,633 $77,000
Q2 2023 Jul 18, 2023	BUY	$21.59 - $27.88 $37,739 - $48,734	1,748 Added 192.94%	2,654 $65,000
Q1 2023 Apr 13, 2023	BUY	$23.46 - $36.44 $7,155 - $11,114	305 Added 50.75%	906 $21,000
Q4 2022 Jan 23, 2023	SELL	$27.82 - $44.16 $389 - $618	-14 Reduced 2.28%	601 $0
Q3 2022 Oct 26, 2022	BUY	$16.33 - $51.06 $10,042 - $31,401	615 New	615 $25,000

Others Institutions Holding SAVA

# of Institutions

201

Shares Held

13.9M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$8.85 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$6.94 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$3.2 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$2.77 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$1.6 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account